Molecular breast imaging

Expert Review of Anticancer Therapy

Volumn 9, Issue 8, 2009, Pages 1073-1080

  O'Connor, Michael ^a   Rhodes, Deborah ^a   Hruska, Carrie ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast cancer; Breast MRI; Mammography; Molecular breast imaging; Screening; Tc 99m sestamibi

Indexed keywords

BISMUTH; FLUORODEOXYGLUCOSE F 18; LUTETIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; SILICATE; SUCCIMER TC 99M; TETROFOSMIN TC 99M;

BREAST; BREAST CANCER; BREAST LESION; CANCER RISK; CANCER SIZE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; ECHOMAMMOGRAPHY; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MOLECULAR IMAGING; NUCLEAR MEDICINE; REVIEW; SCINTILLATION CAMERA; SCREENING; SEMICONDUCTOR; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; GAMMA CAMERAS; HUMANS; MAMMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 70350630440     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.75     Document Type: Review

References (37)

1. Berry DA, Cronin KA, Plevritis SK et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med. 353, 1784-1792 (2005).
2. Mushlin AI, Kouides RW, Shapiro DE. Estimating the accuracy of screening mammography: a meta-analysis. Am. J. Prev. Med. 14(2), 143-153 (1998).
3. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the USA Preventive Services Task Force. Ann. Intern. Med. 137, 347-360 (2002). (Pubitemid 34977137)
4. Sardanelli F, Podo F, D'Agnolo G et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 242, 698-715 (2007). •• Large multicenter study that highlights the limitations of mammography in women at high risk of breast cancer. (Pubitemid 46310082)
5. Lehman CD. Role of MRI in screening women at high risk for breast cancer. J. Magn. Reson. Imaging. 24, 964-970 (2006).
6. Leconte I, Feger C, Galant C et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. Am. J. Roentgenol. 180, 1675-1679 (2003). (Pubitemid 36687107)
7. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast ultrasound and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225, 165-175 (2002).
8. Pisano ED, Gatsonis C, Hendrick E et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N. Engl. J. Med. 353(17), 1773-1783 (2005). • A 50,000 patient study comparing digital and film mammography. (Pubitemid 41549889)
9. Berg WA, Blume JD, Cormack JB et al. For the ACRIN 6666 investigators combined screening with ultrasound and mammography versus mammography alone in women at elevated risk of breast cancer. JAMA 299(18), 2151-2163 (2008). • ACRIN multicenter study comparing ultrasound to mammography.
10. Saslow D, Boetes C, Burke W, et al American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA. Cancer J. Clin. 57, 75-89 (2007). • Provides overview of strengths and limitations of breast MRI. (Pubitemid 46535708)
11. Rafferty EA. Digital mammography: novel applications. Radiol. Clin. North Am. 45(5), 831-843 (2007).
12. Weismann CF, Datz L. Diagnostic algorithm: how to make use of new 2D, 3D and 4D ultrasound technologies in breast imaging. Eur. J. Radiol. 64(2), 250-257 (2007). (Pubitemid 47588757)
13. Karellas A, Vedantham S. Breast cancer imaging: a perspective for the next decade. Med. Phys. 35(11), 4878-4897 (2008).
14. Alizad A, Whaley DH, Greenleaf JF, Fatemi M. Critical issues in breast imaging by vibro-acoustography. Ultrasonics 44 (Suppl. 1), e217-e220 (2006). (Pubitemid 44969867)
15. Raylman RR, Majewski S, Smith MF et al. The positron emission mammography/ tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements. Phys. Med. Biol. 53(3), 637-653 (2008).
16. Taillefer R. The role of 99mTc sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin. Nucl. Med. 29, 16-40 (1999). (Pubitemid 29061428)
17. Waxman AD. The role of (99m) Tc methoxyisobutylisonitrile in imaging breast cancer. Semin. Nucl. Med. 27, 40-54 (1997).
18. Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C. High resolution scintimammography: a pilot study. J. Nucl. Med. 43, 909-915 (2002). (Pubitemid 34747814)
19. Coover LR, Caravaglia G, Kuhn P. Scintimammography with dedicated breast camera detects and localizes occult carcinoma. J. Nucl. Med. 45, 553-558 (2004). (Pubitemid 47618584)
20. Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T, Mathur V. Breast-specific γ imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology 247, 651-657 (2008).
21. Brem RF, Fishman M, Rapelyea JA. Detection of ductal carcinoma in situ with mammography, breast specific γ imaging, and magnetic resonance imaging: a comparative study. Acad. Radiol. 14, 945-950 (2007). (Pubitemid 47058994)
22. Avril N, Rosé CA, Schelling M et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J. Clin. Oncol. 18, 3495-3502 (2000). (Pubitemid 30783328)
23. Raylman RR, Majewski S, Smith MF et al The positron emission mammography/ tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements. Phys. Med. Biol. 53, 637-653 (2008).
24. Schilling K, Conti P, Adler L, Tafra L. The role of positron emission mammography in breast cancer imaging and management. Applied Radiol. 37, 26-36 (2008). (Pubitemid 351586209)
25. Berg WA, Weinberg IN, Narayanan D, et al. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J. 12, 309-323 (2006). (Pubitemid 43989975)
26. Hruska CB, O'Connor MK, Collins DA. Comparison of small field of view γ camera systems for scintimammography. Nucl. Med. Commun. 26, 441-445 (2005). •• Head-to-head comparison of the various technologies available for small field of view γ cameras.
27. Hruska CB, O'Connor MK. Development of a lesion quantification method for dual-head molecular breast imaging. Med. Phys. 35, 1365-1376 (2008).
28. Hruska CB, Phillips SW, Whaley DH, Rhodes DJ, O'Connor MK. Molecular breast imaging: use of a dual-head dedicated γ camera for detection of small breast tumors. AJR Am J Roentgenol. 191, 1805-1815 (2008). • Shows advantages of a dual-head system compared with a single-head system in detecting small breast lesions.
29. O'Connor MK, Phillips SW, Hruska CB, Rhodes DJ, Collins DA. Molecular breast imaging: advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J. 13, 3-11 (2007).
30. Hruska CB, Boughey JC, Phillips SW et al. Molecular breast imaging: a review of the Mayo clinic experience. Am. J. Surg. 196, 470-476 (2008).
31. Hruska CB, Phillips SW, Rhodes DJ, O'Connor MK. Concordance of molecular breast imaging and breast MRI findings: a retrospective review. Eur. J. Nucl. Med. Mol. Imag. 35 (Suppl. 2), S200 (2008).
32. Hruska CB, Rhodes DJ, Phillips SW, Whaley DH, Alabin TT, O'Connor MK, Molecular breast imaging for breast cancer screening in women with mammographically dense breasts and increased risk. [abstract]. Eur. J. Nucl. Med. Mol. Imag. 35(Suppl. 2), S200 (2008). •• Abstract only, but presents important data on advantages of molecular breast imaging over mammography in a screening environment.
33. Hesse B, Tägil K, Cuocolo A. et al. EANM/ESC Procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J. Nucl. Med. 32, 855-897 (2005). (Pubitemid 41125431)
34. Bach-Gansmo T, Danielsson R, Saracco A, et al. Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692. J. Nucl. Med. 47(9), 1434-1439 (2006) (Pubitemid 47544928)
35. Bryant J, Yang D, Schechter N et al. Evaluation of Tc-99m-EC-DG in lung cancer patients. J. Nucl. Med. 48(Suppl. 2), 354P (2007).
36. Papantoniou V, Tsiouris S, Koutsikos J et al. Scintimammographic detection of usual ductal hyperplasia with increased proliferation rate at risk for malignancy. Nucl. Med. Commun. 27, 911-917 (2006). (Pubitemid 44526730)
37. Mansi L, Rambaldi PF, Procaccini E et al Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur. J. Nucl. Med. 23, 932-939 (1996). (Pubitemid 26278793)